DuPont, through its wholly-owned subsidiary DuPont Denmark Holding ApS, announced that it successfully completed its tender offer for all outstanding shares of common stock of Danisco for DKK 700 (US$131.38) cash per share.
All shares that were properly tendered have been accepted for purchase, according to the company.
“We are delighted that the tender has been successful and we can move on to the process of integrating Danisco into DuPont,” said Ellen Kullman, DuPont chair and chief executive. “Danisco’s attractive specialty food ingredients businesses and Genencor’s leading industrial enzymes complement DuPont’s own Nutrition & Health and Applied BioSciences offerings. This combination will create an industry leader in industrial biosciences and nutrition and health.”
